GELTEQ LIMITED ORDINARY SHARES

NASDAQ: GELS (Gelteq Limited)

Last update: 25 Mar, 5:08PM

1.06

-0.01 (-0.93%)

Previous Close 1.07
Open 1.05
Volume 10,016
Avg. Volume (3M) 180,798
Market Cap 10,004,364
Price / Book 1.04
52 Weeks Range
0.950 (-10%) — 5.50 (418%)
Operating Margin (TTM) -2,518.17%
Diluted EPS (TTM) -0.240
Quarterly Revenue Growth (YOY) 56.80%
Total Debt/Equity (MRQ) 25.43%
Current Ratio (MRQ) 0.080
Operating Cash Flow (TTM) -1.07 M
Return on Assets (TTM) -8.04%
Return on Equity (TTM) -21.00%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Gelteq Limited - -

AIStockmoo Score

0.3
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 1.0
Technical Oscillators -0.5
Average 0.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GELS 10 M - - 1.04
ZYBT 245 M - 86.14 6.59
BIOA 161 M - - 0.500
CTOR 57 M - - 1.38
SHPH 3 M - - 3.60
CANB 2 M - 0.344 33.49

Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
% Held by Insiders 60.36%
% Held by Institutions 0.86%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria